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Abstract
Background: Identification of subgroups of patients with different levels of sensitization and clinical features can
help to identify groups at risk and the development of better therapeutic strategies. The aim of this study was to
identify subgroups of patients with tension type headache (TTH) with different levels of sensitization, clinical pain
features, and psychological outcomes.
Methods: A total of 197 individuals with TTH participated. Headache intensity, frequency, and duration and
medication intake were collected with a 4-weeks diary. Pressure pain thresholds were assessed bilaterally over
the temporalis muscle, C5-C6 joint, second metacarpal and tibialis anterior muscle to determine widespread
pressure pain hyperalgesia. The Hospital Anxiety and Depression Scale assessed anxiety and depression. The
State-Trait Anxiety Inventory evaluated the state and trait levels of anxiety. The Headache Disability Inventory
evaluated the burden of headache. Health-related quality of life was determined with the SF-36 questionnaire.
Groups were considered as positive (three or more criteria) or negative (less than three criteria) on a clinical
prediction rule: headache duration <8.5 h/day; headache frequency <5.5 days/week; bodily pain <47 and
vitality <47.5.
Results: The ANCOVA revealed that subjects in group 1 (positive rule, n = 89) exhibited longer headache
history, shorter headache duration, lower headache frequency, higher widespread pressure hyperalgesia, higher
anxiety trait levels, and lower quality of life (all, P < 0.01) than those subjects within group 2 (negative rule, n = 108).
Differences were similar between men and women.
Conclusions: This study identified a subgroup of patients with TTH with higher sensitization, higher chronicity of
headaches and worse quality of life but lower frequency and duration of headache episodes. This subgroup of individuals
with TTH may need particular attention and specific therapeutic programs for avoiding potential chronification.
Keywords: Tension type headache, Pain, Groups, Sensitization
Background
Tension-type headache (TTH) affects up to 80% of the
general population at sometime during their life and
shows a global prevalence in adults of 42% [1]. The general
health costs for headaches in Europe were €13.8 billion,
most related to migraine and TTH [2]. In fact, TTH has
been found to be the second most prevalent disorder in
the world [3]; although it has received far less attention
than migraine.
Although the mechanisms underlying the transition
from episodic to chronic TTH are not fully understood,
the existing literature supports that sensitization mecha-
nisms play an important role [4, 5]. In fact, the most ac-
cepted theory is that frequent episodic TTH is peripheral
dominant whereas chronic TTH involves more central
components [6]. This hypothesis is based on several studies
supporting the presence of pressure pain hyperalgesia in
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the trigemino-cervical area as a manifestation of altered
nociceptive pain processing in TTH [7]. Nevertheless,
pressure pain hypersensitivity within the trigeminal area
may reflect both peripheral and central sensitization pro-
cesses. The presence of widespread pressure pain hyper-
sensitivity in distant pain-free areas in TTH supports the
role of central sensitization [8, 9].
Identification of subgroups of patients with different
levels of sensitization can help to better understanding
of chronic and complex pain conditions, such as TTH,
and to identify better therapeutic strategies. For instance,
a subgroup of individuals with knee osteoarthritis (those
with higher pain intensity but minimal radiographic
change in the knee) exhibiting strong sensitization has
been identified [10]. In individuals with chronic whiplash
associated disorders higher widespread pressure sensitivity
and cold sensitivity have been associated with higher dis-
ability levels [11]. There is a lack of studies investigating
sub-classification in individuals with TTH. A clinical pre-
diction rule to identify women with TTH who will be
likely to respond favorably to a particular manual therapy
approach was identified, but not validated [12]. The re-
sults identified 4 variables that were predictive of a posi-
tive outcome: headache duration <8.5 h/day, headache
frequency < 5.5 days/week, bodily pain <47 points and
vitality <47.5 points. If a patient presented with 3 of these
4 variables, the positive likelihood ratio was 3.4 (95%CI
1.4, 8.0) with a posttest probability of success of 80% [12].
It is possible that these variables can be also able to iden-
tify groups of patients with TTH with different levels of
sensitization or clinical features. In fact, a similar pro-
cedure was recently observed in women with carpal
tunnel syndrome where those positive on a clinical
prediction rule for physical therapy exhibited higher
pressure and thermal pain hyperalgesia and higher de-
pressive levels than those negative on the rule [13].
Therefore, the aim of the current study was to characterize
groups of patients with TTH by determining if those vari-
ables previously associated with a positive outcome for
manual therapy are also able to identify patients with TTH
with more central sensitization and worse clinical features.
Methods
Participants
A cross-sectional study was conducted. Individuals with
headache were recruited from different university-based
hospitals between January 2015 and December 2016. All
diagnoses were performed following the criteria of the
International Classification of Headache Disorders
(ICHD-III beta, 2013) by neurologists, expert in head-
aches [14]. To be included subjects had to exhibit all
pain features of TTH; report no more than one among
photophobia, phonophobia or mild nausea, and no
moderate/severe nausea or vomiting as requested by
the ICHD-III diagnostic criteria [14]. A 4-weeks head-
ache diary was used to substantiate the diagnosis and
to obtain the headache features [15]. On the headache
diary, participants registered the number of days with
headache (days/week), the duration of headache episodes
(hours/day), and the intensity of pain of each episode on
an 11-points numerical pain rate scale (NPRS; 0: no pain;
10: the worst unimaginable pain) [16]. Further, the use of
symptomatic and preventive medication intake was also
recorded in the diary.
Participants were excluded if presented any of the
following criteria: 1, any other primary or secondary
headache including medication overuse headache as
defined by the ICHD-III; 2, previous cervical or head
trauma; 3, cervical herniated disk or cervical osteoarth-
ritis on medical records; 4, systemic medical disease; 5,
fibromyalgia syndrome; 6, had received physical therapy
or anesthetic blocks in the head/neck within the previ-
ous 6 months; or, 7, pregnancy. All subjects read and
signed a written consent form prior to their participation
in the study. The study design was approved by the local
Ethics Committees (URJC 23/2014, HRJ 07/14, Aalborg
N20140063, CESU 5/2015) and was conducted following
the Helsinki declaration.
Evaluations were conducted when patients were
headache-free or, in those with a high frequency of
headaches, when the intensity of pain was ≤3 points on
the NPRS. They were asked to avoid any analgesic or
muscle relaxant 24 h prior to examination. No change
was made on their regular pharmacological treatment.
Pressure pain thresholds
An electronic pressure algometer (Somedic® Algometer,
Sollentuna, Sweden) was used to measure pressure pain
thresholds (PPT) over the temporalis muscle, C5-C6
zygapophyseal joint, second metacarpal and tibialis an-
terior muscle. PPT is defined as the minimal amount of
pressure where a sense of pressure first changes to pain.
Participants were instructed to press the “stop-button”
of the algometer as soon as the pressure resulted in a
first sensation of pressure and pain. Pressure was in-
creased at a rate of approximately 30 kPa/s. The mean
of 3 trials on each point, with a 30 s resting period for
avoiding temporal summation of pain [17], was calcu-
lated and used for the main analyses. The order of as-
sessment was randomized between participants and the
assessor was blinded to any other outcome. Participants
practiced first on the wrist extensors of the right fore-
arm. The reliability of pressure algometry has been
found to be high [18, 19].
Headache Disability Inventory (HDI)
The HDI assesses the burden of headache using 25 items
that inquire about the impact of headache on emotional
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functioning and daily activities [20]. Possible answers for
each item include YES (4 points), SOMETIMES (2 point)
or NO (0 points). Thirteen items evaluate the emotional
burden of the headache (HDI-E, maximum score: 52), and
the remaining 12 items the physical burden (HDI-P,
maximum score: 48). A greater score suggests a greater
burden of the headache. The HDI has exhibited good
stability at short and long-terms [21].
State-Trait Anxiety Inventory (STAI)
The STAI is a 40-items scale assessing the state (items l-20,
STAI-S) and trait (items 21–40, STAI-T) levels of anxiety
[22, 23]. The STAI-S evaluates relatively enduring symp-
toms of anxiety where subjects use a 4-points response
scale ranging from “not at all” to “very much”, to indicate
the extent to which they experience each emotion. The
STAI-T scale measures stable propensity to experience
anxiety and tendencies to perceive stressful situations as
threatening. It consists of 20 statements requiring indi-
viduals to rate how they generally feel on a 4-points
scale. Higher scores indicate greater state and/or trait
anxiety levels. Both scales have good internal consistency
and excellent test-retest reliability [24].
Health-related quality of life
The Short-Form Health Survey 36 (SF-36) was used to
assess health-related quality of life. The SF-36 is a self-
administered, 36-items questionnaire that measures
health-related functions on eight domains: physical func-
tion, physical role, bodily pain, general health, vitality,
social function, role-emotional, and mental health [25].
After summing Likert-scaled items, each domain is stan-
dardized ranging from 0 to 100 points according to
established international guidelines where higher scores
represent better quality of life [26].
Sub-grouping
Patients were grouped according if they were positive or
negative in the rule using identical criteria to those pre-
viously reported [12]: headache duration <8.5 h/day;
headache frequency <5.5 days per week; bodily pain <47
points and vitality <47.5 points in the domains of the
SF-36 questionnaire. Patients who met at least three of
the four criteria were classified as positive on the rule
(Group 1), whereas patients meeting two or fewer cri-
teria were classified as negative on the rule (Group 2).
Data analysis
Statistical analysis was performed using SPSS software
version 20.0 (Chicago, IL, USA). Patients were grouped
according to the rule [12]. Differences between groups in
clinical features, burden of headache (HDI-E, HDI-P), de-
pression (HADS-D), anxiety (HADS-A, STAI-T, STAI-S)
and each domain of SF-36 questionnaire were compared
using one-way analysis of covariance (ANCOVA) with
gender as covariate, and χ2 test of independence for
categorical data. A two-way ANCOVA was used to evalu-
ate differences in PPTs with side (right/left) as within-
subjects factor, group (positive or negative rule) as the
between-subjects factor and gender as covariate. The
normality and homogeneity criteria were checked for
dependent variables with Kurtosis and Skewness for the
normality and Levene’s test for the homogeneity criteria.
Separate ANOVAs were performed for each variable. As
multiple comparisons were conducted in the main analysis,
a Bonferroni-corrected alpha level of 0.025 (2 independent-
samples t tests) was required to support the validity of the
sub-groups.
Results
Two hundred and twenty-five (n = 225) subjects with
headache were screened for possible eligibility criteria.
Of these, 197 patients (72% women) satisfied all the eli-
gibility criteria, agreed to participate and signed the
written informed consent. The reasons for exclusion
were co-morbid migraine (n = 15), fibromyalgia (n = 5),
medication overuse headache (n = 4), or previous whip-
lash (n = 4). One hundred and nine (n = 109, 56.5%)
were classified as frequent episodic tension type
headache (FETTH), and 88 (44.5%) were classified as
chronic tension type headache (CTTH) accordingly to
the ICHD-III diagnostic criteria. Fifty-five (28%) were
taking prophylactic intake, i.e., amitriptyline, on a regu-
lar basis, and 136 (69%) took symptomatic medication,
i.e., NSAIDs, during the headache episodes. Eighty-nine
individuals (45%) were classified as group 1 (positive
rule) whereas 108 (55%) were classified as group 2
(negative rule).
Headache clinical features and medication intake
Table 1 summarizes demographic and clinical data of
each group in the total sample. The ANCOVA re-
vealed significant differences between groups for years
with headache (F = 5.748; P = 0.02), headache duration
(F = 7.836; P < 0.001) and headache frequency (F = 17.148;
P < 0.001), but not for age (F = 0.813; P = 0.488) or head-
ache intensity (F = 0.904; P = 0.333): patients in group 1
showed longer history of headache, shorter headache
duration, and lower frequency of episodes than those
patients within group 2. No interaction of gender was
observed for either outcome (age: F = 0.367, P = 0.545;
years with headache: F = 0.573, P = 0.450; headache inten-
sity: F = 0.919, P = 0.433; headache duration: F = 0.182, P =
0.670; headache frequency: F = 0.187, P = 0.666). A signifi-
cant (χ2 = 11.594; P < 0.001) greater proportion of FETTH
subjects were included in group 1.
Finally, no significant differences in the distribution of
gender (χ2 = 0.826; P = 0.363) or medication intake
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(preventive drug: χ2 = 0.441, P = 0.507; symptomatic
drug: χ2 = 0.056, P = 0.813) were found between groups.
Burden of headache and mood disorders
Patients in group 1 exhibited higher anxiety trait
levels (STAI-T) than those within group 2 (F = 7.090;
P = 0.009). No significant differences in the burden of
headache (HDI-P: F = 1.240, P = 0.297; HDI-E: F = 0.499,
P = 0.481), depression (HADS-D: F = 0.010, P = 0.982), or
anxiety levels (HADS-A: F = 1.024, P = 0.384; STAI-S:
F = 0.279, P = 0.599) were found (Table 1). Gender did
not influence the results (HDI-E: F = 0.438, P = 0.509;
HDI-P: F = 0.144, P = 0.705; HADS-D: F = 0.489, P =
0.485; HADS-A: F = 0.013, P = 0.909; STAI-S: F = 0.038,
P = 0.847; STAI-T: F = 1.899, P = 0.171).
Widespread pressure pain sensitivity
The two-way ANCOVA revealed significant differences
between groups, but not between sides, for PPTs over all
the points: temporalis muscle (group: F = 9.576, P = 0.002;
side: F = 1.249, P = 0.304), C5-C6 joint (group: F = 12.739,
P < 0.001; side: F = 0.819, P = 0.366), second metacarpal
(group: F = 14.849, P < 0.001; side: F = 1.026, P = 0.312),
tibialis anterior muscle (group: F = 10.626, P < 0.001; side:
F = 0.346, P = 0.557). No significant side * group interac-
tions were found. Patients within group 1 exhibited
bilateral lower widespread PPT than those within group 2
(Fig. 1). A significant effect of gender was also found:
temporalis muscle (F = 13.15, P < 0.001), C5-C6 joint
(F = 12.46, P < 0.001), second metacarpal (F = 16.317,
P < 0.001), tibialis anterior muscle (F = 11.435, P < 0.001).
No group * gender interaction was either observed. PPTs
were significantly lower in women than in men in both
groups. Table 2 summarizes PPTs in all the assessed
points within each group.
Health-related quality of life
The ANCOVA revealed significant differences in all
domains of the SF-36 questionnaire (physical function:
F = 6.600, P = 0.011; physical role: F = 4.428, P = 0.014;
bodily pain: F = 7.654, P < 0.001; general health: F =
4.715, P = 0.018; vitality: F = 8.805, P < 0.001; social
function: F = 8.076 P < 0.001; role-emotional: F = 7.099,
P = 0.001) except mental health (F = 1.503, P = 0.195).
Patients from group 1 exhibited lower quality of life than
those patients from group 2 (Table 3). No effect of
gender was observed for any SF-36 domain (physical
function: F = 0.045, P = 0.833; physical role: F = 0.1704,
P = 0.747; bodily pain: F = 0.108, P = 0.743; general
health: F = 0.096, P = 1.482; vitality: F = 0.661, P = 0.417;
social function: F = 0.890, P = 0.347; role-emotional: F =
0.652, P = 0.761) mental health: F = 0.659, P = 0.418).
Discussion
The current study has identified a subgroup of pa-
tients with TTH with higher widespread pressure pain
Table 1 Clinical features, medication intake, psychological and related-disability outcomes in patients with tension-type headache
by group
Group 1 (Rule positive, n = 89) Group 2 (Rule negative, n = 108)
Clinical Pain Features
Gender (male/female) n (%) 22 (25%)/67 (75%) 33 (30%)/75 (70%)
Age (years) 44.8 (41.5, 48.1) 45.8 (42.8, 48.8)
Headache history (years)* 12.9 (10.0, 15.8) 8.8 (6.9, 10.8)
Headache intensity (0-10) 5.3 (4.6, 6.0) 5.1 (4.7, 5.5)
Headache frequency (days/)* 3.7 (3.2, 4.2) 6.0 (5.5, 6.5)
Headache duration (hours per attack)* 5.7 (5.0, 6.4) 8.1 (7.3, 8.9)
FETTH/CTTH n (%)* 60 (67.5%)/29 (32.5%) 49 (45.5%)/59 (55.5%)
Preventive medication (yes/no) n (%) 24 (27%)/65 (73%) 31 (28.5%)/77 (71.5%)
Symptomatic medication (yes/no) n (%) 61 (68.5%)/28 (32.5%) 75 (69.5%)/33 (31.5%)
Psychological and disability-related outcomes
HADS-D (0–21) 7.8 (6.8, 8.7) 7.8 (6.8, 8.8)
HADS-A (0–21) 9.6 (8.7, 10.6) 10.0 (8.9, 11.1)
HDI-P (0–48) 24.9 (22.2, 27.6) 23.1 (20.5, 25.7)
HDI-E (0–52) 19.7 (16.6, 22.9) 18.3 (15.5, 21.1)
STAI-T (0–60)* 25.8 (23.8, 27.8) 22.1 (20.7, 23.5)
STAI-S (0–60) 21.3 (19.7, 22.9) 21.8 (20.6, 23.0)
HADS Hospital Anxiety and Depression Scale (D Depression; A Anxiety), HDI Headache Disability Inventory (P Physical; E Emotional), STAI State-Trait Anxiety Inventory
(T Trait; S State)
Values are expressed as means (95% confidence interval); *Significant differences between groups (ANOVA, P < 0.01)
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hyperalgesia, longer headache history and lower health-
related quality of life but lower frequency and shorter
duration of headache episodes. This classification was
conducted accordingly to a clinical prediction rule origin-
ally developed for identifying women with TTH who were
likely to respond favorably to a manual therapy targeting
muscle tissues [12].
The group of patients with TTH exhibiting higher
pressure hyperalgesia and worse quality of life was iden-
tified by applying a simple classification rule [12]. This
classification system could potentially help to identify
patients with TTH at a higher risk for developing more
severe TTH (e.g., transition from episodic to chronic). In
fact, it is also possible that this subgroup of patients with
higher levels of sensitization would be more susceptible
for developing widespread symptoms representing the
35–44% of sufferers with TTH presenting co-morbid
fibromyalgia syndrome [27]. This hypothesis would be
also supported by the worse health-related quality of life
experienced by this subgroup of patients albeit they ex-
hibited lower frequency and shorter duration of head-
ache episodes since patients with TTH and co-morbid
widespread symptoms experience worse health-related
quality of life [28]. This maybe particularly relevant for
the lower scores in one of the domains of the rule, bod-
ily pain, which represents the experience of body pain
symptoms by the patient. Nevertheless, the presence of
higher sensitization in patients with lower frequency of
headaches is contrary to what is observed in patients
with migraine and co-morbid fibromyalgia syndrome
since a higher frequency of migraine attacks enhances
both hyperalgesia and widespread pain symptoms [29].
We do not currently know if the presence of widespread
hypersensitivity appears before or after the increase of
the frequency of headaches, or both processes are inter-
connected and therefore one promotes the other.
The presence of higher widespread pain sensitization
may suggest different underlying mechanisms in this
Fig. 1 Differences in widespread pressure pain thresholds (kPa) between patients positive (group 1) or negative (group 2) in the rule. Data are
expressed as means and standard error (SE). * Significant differences between groups (P < 0.01)
Table 2 Differences in pressure pain thresholds (PPT, kPa) between individuals with tension-type headache by group
Temporalis muscle* C5-C6 zygapophyseal joint* Second metacarpal* Tibialis anterior muscle*
Group 1 (Rule positive, n = 89)
Right side 200.0 (179.6, 220.3) 220.4 (174.5, 230.2) 238.7 (216.6, 261.0) 386.0 (341.2, 430.9)
Left side 192.0 (171.6, 212.3) 192.4 (164.6, 220.2) 229.2 (207.1, 251.5) 379.7 (334.9, 424.6)
Group 2 (Rule negative, n = 108)
Right side 238.7 (220.1, 257.4) 253.0 (227.6, 278.5) 281.8 (261.6, 302.0) 464.1 (423.0, 505.2)
Left side 214.5 (195.8, 233.1) 238.5 (213.0, 263.9) 269.4 (248.9, 289.8) 444.6 (403.1, 486.1)
Values are expressed as means (95% confidence interval)
*Significant differences between both groups (2-two way ANOVA test, P < 0.001)
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group of patients. It is accepted that prolonged noci-
ception from peripheral tissues, i.e., muscles, is the
main responsible for triggering centralized sensitization
mechanisms and the evolution from the episodic to the
chronic form [6, 30]. In the chronification process, the
frequency of the headache episodes is found to play an
important role [31]. However, our study found that the
subgroup of patients exhibiting higher widespread pres-
sure pain hypersensitivity reported lower frequency of
headaches. This is supported by the fact that there was
a greater distribution of patients with FETTH within
group 1. Other possibility is that higher chronicity
(history with pain symptoms) of headache can also ex-
plain higher sensitization levels [32]. We also observed
that the group of patients with TTH with higher
sensitization levels also exhibited a longer history of
headache, supporting this hypothesis. This finding
would suggest that, not only the frequency of head-
aches as previously reported, but also the chronicity of
symptoms, may be also relevant for the development of
central sensitization. Therefore, early therapeutic interven-
tions for preventing development of central sensitization
should be encouraged in this subgroup. An interesting
finding was that the identified subgroup of patients with
TTH with higher levels of sensitization also exhibited
higher trait anxiety. Since stress is one of the most com-
mon trigger and aggravating factors of TTH [33, 34], it is
possible that this subgroup of subjects would be more
susceptible to stressful situations and therefore promoting
development of central sensitization. Therefore, psycho-
logical approaches targeting anxiety trait levels should be
also implemented in this subgroup of patients. Finally, it is
also possible that this subgroup of patients with TTH
exhibits different neurotransmitter concentrations or
differences in brainstem processing [35] explaining the al-
tered nociceptive processing; although this hypothesis
should be investigated in future studies.
Although this is the first study investigating a classifica-
tion system in patients with TTH, we should recognize
some potential limitations. First, we recruited our patients
from tertiary care hospitals; therefore, multi-center studies
including individuals from the general population would
help to extrapolate the results. Second, we only tested the
response to pressure stimulation as it has been previously
found that pressure pain sensitivity is a clear feature of
TTH [6, 7]. It would be interesting to investigate other
outcomes of central sensitization, e.g., thermal pain
thresholds, conditioning pain modulation (CPM) or noci-
ception flexor reflex (NFR) in these subgroups of patients
with TTH.
Conclusions
Patients with TTH who meet a clinical prediction for
group 1 (at least 3 of the criteria) tended to exhibit higher
widespread pressure hyperalgesia, longer headache history,
higher trait anxiety levels, and worse quality of life but
lower frequency and shorter duration of headache episodes
than those within group 2 (met two or fewer criteria).
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